Skip to main content
Caplight Logo









Redx Pharma Plc

Redx Pharma Plc

Private
MacclesfieldHealthcare & Life Scienceshttps://www.redxpharma.com/

Last Round

Series A

Aug 14, 2026

Est. Valuation

$214.65M

Total Funding Raised

$29M

Momentum

Top 1%

of companies Caplight tracks

Company Overview

Redx Pharma Plc is a clinical-stage biotechnology company that discovers and develops novel, small molecule, targeted medicines for the treatment of fibrotic disease and cancer.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting

AI Layer

Non-AI

Keywords

biotechnologysmall molecule therapeuticsdrug discoveryROCK inhibitorsfibrotic diseasesoncologyclinical-stage biotechdrug licensingmedicinal chemistrytranslational sciencebiotech pipelinepharma partneringdrug developmentbiotech startup

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Redx Pharma Plc Comparables

Compare Redx Pharma Plc with similar companies based on industry and business-model similarity.

Redx Pharma Plc comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Graviton BioScience
81%
Vicore Pharma
78%
Contineum Therapeutics
75%

Redx Pharma Plc Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AAug 14, 2026
Private PlacementOct 18, 2023
Private PlacementMay 19, 2022
Private PlacementDec 2, 2020
Convertible DebtAug 4, 2020
Private Placement
Jul 21, 2020

Key People

Founding team and executive leadership

Lisa Anson

Chief Executive Officer

Executive Team

Peter Collum

Chief Financial Officer

Executive Team

James Mead

Chief Operating Officer

Executive Team

Redx Pharma Plc Investors

Notable investors and investment history

Redx Pharma Plc investors
InvestorRounds
Redmile GroupConvertible Debt, Private Placement, Series A
Polar CapitalPrivate Placement
Platinum Asset ManagementPrivate Placement
British Business BankSeries A
AbingworthSeries A
Sofinnova PartnersConvertible Debt, Private Placement
InvusPrivate Placement

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 14, 2026

    $36M round led by Abingworth.

  • Jan 21, 2026

    Monthly visitors increased 50% MoM, reaching 6.6K.

Redx Pharma Plc Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Redx Pharma Plc Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Redx Pharma Plc's valuation, stock price, and market status.

Firmographic Details

HeadquartersMacclesfield
Employee Range39
Year Founded2010
Last FundingAug 14, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?